Darmiyan

our first product is brainSee:
fDA-breakthrough, pending marketing approval

BrainSee Is A Medical Device

BrainSee is a clinical software designed to be used as a medical device in the clinical setting to aid in the prognosis of patients who have amnestic mild cognitive impairment (aMCI).

BrainSee is a novel AI algorithm running in the cloud that processes patient medical data and gives a score (between 0 and 100%) that reflects the likelihood of progression from mild cognitive impairment to Alzheimer’s dementia within 5 years.